Polee, M.B.

patient cancer paclitaxel study cisplatin treatment chemotherapy response oesophageal cancer oesophageal disease survival carboplatin phase toxicity month combination carcinoma grade surgery response rate trial cell carcinoma phase i study oesophagu 5- fluorouracil regimen phase ii study fluorouracil course factor level metastatic phase ii trial resection administration schedule tumour infusion table result oncol randomised adenocarcinoma etoposide metastatic disease dose level response rates cycle range pharmacokinetic metastase lymph analysis performance esophageal cancer neurotoxicity lymph node metastases esophageal folinic acid neutropenic fever dose intensity radiotherapy prognostic delay agent van der gaast therapy metastatic oesophageal cancer resectable group randomised trial evaluation prognostic factors patienten number tilanus hw status neutropenic 2 weeks